MoneyWorks4Me

Zydus Lifesciences informs about press release

27 Sep 2024 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated September 27, 2024, titled ‘Zydus and CSIR-Central Drug Research Institute Lucknow to develop best-in-class drug for chronic kidney disease induced Osteoporosis’.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1752.10
Dr. Reddys Labs. 1232.90
Cipla 1330.60
Lupin 1966.30
Zydus Lifesciences 1123.10
View more..